Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death

The Journal of Clinical Investigation
Imran N MungrueMansoor Husain

Abstract

Increased inducible nitric oxide synthase (iNOS) expression is a component of the immune response and has been demonstrated in cardiomyocytes in septic shock, myocarditis, transplant rejection, ischemia, and dilated cardiomyopathy. To explore whether the consequences of such expression are adaptive or pathogenic, we have generated a transgenic mouse model conditionally targeting the expression of a human iNOS cDNA to myocardium. Chronic cardiac-specific upregulation of iNOS in transgenic mice led to increased production of peroxynitrite. This was associated with a mild inflammatory cell infiltrate, cardiac fibrosis, hypertrophy, and dilatation. While iNOS-overexpressing mice infrequently developed overt heart failure, they displayed a high incidence of sudden cardiac death due to bradyarrhythmia. This dramatic cardiac phenotype was rescued by specific attenuation of transgene activity. These data implicate cardiomyocyte iNOS overexpression as sufficient to cause cardiomyopathy, bradyarrhythmia, and sudden cardiac death.

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M Gossen, H Bujard
Nov 1, 1992·The Journal of Clinical Investigation·R DongM J Sole
Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·D J StuehrC F Nathan
Aug 1, 1990·Circulation Research·Y KusamaD J Hearse
Oct 1, 1967·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A El-Badawi, E A Schenk
Jun 1, 1995·Annals of Medicine·E NavaT F Lüscher
Jan 9, 1993·Lancet·A J de BelderS Moncada
Mar 15, 1996·Circulation·G A HaywoodM B Fowler
Oct 1, 1996·Circulation Research·Z YuG I Fishman
Jun 24, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y Xia, J L Zweier
Jul 15, 1997·The Journal of Clinical Investigation·M ShimabukuroR H Unger
Nov 20, 1997·The Journal of Clinical Investigation·C Nathan
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J Vásquez-VivarK A Pritchard
Nov 21, 1998·European Journal of Clinical Investigation·M Guslandi
Oct 20, 1999·Journal of Molecular and Cellular Cardiology·B L BiaK Clarke
Jan 1, 2000·Cardiovascular Research·J E JordanJ Vinten-Johansen
May 26, 2001·The Journal of Clinical Investigation·K NakamuraM Michalak
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·H JuM Rabinovitch

❮ Previous
Next ❯

Citations

Dec 4, 2010·Heart Failure Reviews·Hani N SabbahRamesh C Gupta
Apr 25, 2012·Current Cardiology Reports·Hani N Sabbah
Dec 13, 2012·Current Hypertension Reports·Robrecht ThoonenEmmanuel S Buys
Jun 1, 2005·Trends in Pharmacological Sciences·Pal PacherCsaba Szabó
Jan 29, 2008·The Journal of Biological Chemistry·Karin KaiserovaAruni Bhatnagar
Jul 20, 2005·The Journal of Experimental Medicine·Kanji MinamotoDavid J Pinsky
Feb 11, 2009·Evidence-based Complementary and Alternative Medicine : ECAM·Guangde YangRong Lin
Aug 13, 2004·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Claire E SearsBarbara Casadei
Feb 4, 2010·Molecular and Cellular Biology·Aline LaraSilvia Guatimosim
Mar 25, 2011·American Journal of Physiology. Cell Physiology·Suxin LuoYong Xia
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Qianhong LiRoberto Bolli
Jan 24, 2007·Physiological Reviews·Pál PacherLucas Liaudet
Oct 8, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Suguru YamamotoValentina Kon
Feb 3, 2006·The Journal of Clinical Investigation·Yasushi MukaiJames K Liao
Nov 8, 2006·Molecular Medicine·Andrea MolnárCsaba Szabó
Nov 16, 2013·International Journal of Molecular Sciences·Martin L Pall
Oct 14, 2011·Cleveland Clinic Journal of Medicine·Hani N Sabbah
Jun 2, 2011·Free Radical Biology & Medicine·Koichi Sugamura, John F Keaney
Mar 1, 2011·Journal of Molecular and Cellular Cardiology·Stella YuenMary Anne Opavsky
Oct 2, 2012·FEBS Letters·Péter Bai, László Virág
Oct 6, 2009·Journal of Molecular and Cellular Cardiology·J Craig HunterMorris Karmazyn
Aug 30, 2008·Journal of Molecular and Cellular Cardiology·Mark T ZioloHonglan Wang
Apr 22, 2015·Current Treatment Options in Cardiovascular Medicine·William A HuangMarmar Vaseghi
Nov 27, 2007·European Journal of Pharmacology·Yagna P R JarajapuHarm J Knot
Sep 10, 2020·Frontiers in Cell and Developmental Biology·Baoyu ChenYong Xu
Jun 21, 2019·JCI Insight·Qiyang ShouYiping Yang
Jul 26, 2021·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Nicolle J DomnikDamian P Redfearn

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR
fluorescence imaging
biopsy

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.